Dr. David Binion, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 98
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: State University of New York at Buffalo School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
PA license MD434391
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
- Magee Womens Hospital of UPMC Health System Pittsburgh, PA
- UPMC PAssavant Pittsburgh, PA
- St Clair Hospital Pittsburgh, PA
- Washington Hospital, the Washington, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 98
- Services billed
- 256
- Patients’ average age
- 64
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 164 | 92 |
| Biopsy of large bowel using a flexible endoscope | 15 | 15 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sodium Chloride (0.9 % sodium chloride) Other prescribers in Pittsburgh, PA | 318 |
| Creon (lipase/protease/amylase) Other prescribers in Pittsburgh, PA | 181 |
| Famotidine Other prescribers in Pittsburgh, PA | 178 |
| Stelara (ustekinumab) | 167 |
| Cholestyramine (cholestyramine (with sugar)) Other prescribers in Pittsburgh, PA | 141 |
| Budesonide Dr (budesonide) Other prescribers in Pittsburgh, PA | 113 |
| Lactated Ringers (ringer's solution,lactated) | 112 |
| Colesevelam Hcl Other prescribers in Pittsburgh, PA | 104 |
| Pantoprazole Sodium Other prescribers in Pittsburgh, PA | 99 |
| Montelukast Sodium Other prescribers in Pittsburgh, PA | 98 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $52.45 in total to this clinician.
| Takeda Pharmaceuticals U.S.A., Inc. | $29.25 |
|---|---|
| Janssen Biotech, Inc. | $23.20 |
| Food and Beverage | $52.45 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,354 in research payments for these studies, mostly to the institutions running them.
- Registry for Participants With Short Bowel Syndrome
Takeda Pharmaceuticals U.S.A., Inc. · Active, not recruiting · NCT01990040
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.